+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cold Plasma Market Size, Share & Trends Analysis Report By Pressure (Atmospheric, Low-pressure Cold Plasma), By Application (Cancer Treatment, Wound Healing, Blood Coagulation), And Segment Forecasts, 2019 - 2026

  • PDF Icon

    Report

  • 69 Pages
  • January 2019
  • Region: Global
  • Grand View Research
  • ID: 4751766
The global cold plasma market size is expected to reach USD 198.50 million by 2026 at a strong CAGR of 15.2%. Increasing use of cold plasma in medical treatment and rising cases of Hospital-Acquired Infections (HAI) are the key driving factors for the global market. In healthcare industry, plasma technology has been in use for some time and it continues to help improve various treatments. One of the major properties of cold plasma is the ability to kill bacteria and prevent infection. Therefore, it acts as an effective healing solution. It also accelerates healing process and prevent patient from discomfort.

Cold plasma is used in the treatment of chronic wounds and burns. The bacterial cells, including Multidrug Resistant (MDR) bacteria, are instantly killed after being exposed to cold plasma. As per an article published by the Medical Xpress, Med Tech Europe, around 4.0 million people in Europe suffer from non-healing wounds every year. It also reported that a burn patient in Germany was treated using prototype plasma treatment. Moreover, as per a research published by The National Center for Biotechnology Information (NCBI), a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after the second treatment. Such cases are anticipated to promote the usage of cold plasma in various wound treatments.

Further key findings from the study suggest:
  • In terms of revenue, atmospheric pressure segment is projected to ascend at the fastest CAGR over the forecast period due to rising application scope in various medical procedures

  • Wound healing application segment is expected to witness a significant growth over the forecast period

  • Asia Pacific region is estimated to witness the highest growth due to increased adoption of technologically advanced procedures for treatment of various diseases

  • Rise in disposable income levels and growing target population base are also likely to contribute to the region’s development

  • Some of the key companies in the global cold plasma market are U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity flow analysis (Model 1)
2.6.2 Volume price analysis (model 2)
2.7 List of Secondary Sources
2.8 List of Abbreviations
Chapter 3 Objectives
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the strategy framework and competitor categorization
3.4 Objective - 4: Understanding the scope of the market
Chapter 4 Executive Summary
4.1 Market Snapshot
Chapter 5 Market Definition
Chapter 6 Industry Outlook
6.1 Market Segmentation
6.2 Market Variable Analysis
6.2.1 Market driver analysis
6.2.1.1 Increasing use of cold plasma in medical treatment
6.2.1.2 Increasing hospital acquired infections (HAI)
6.2.2 Market restraint analysis
6.2.2.1 Lack of awareness about cold plasma technology
6.2.3 Penetration and growth prospect mapping
6.3 Penetration & Growth Prospect Mapping
6.4 Business Environment Analysis tools
6.4.1 SWOT Analysis, by PEST
6.4.2 Porter’s five forces analysis
Chapter 7 Pressure Segment Analysis
7.1 Cold Plasma Market: Pressure Movement Analysis
7.2 Low-Pressure Cold Plasma
7.2.1 Low-pressure cold plasma market, 2014-2026 (USD Million)
7.3 Atmospheric Cold Plasma
7.3.1 Atmospheric cold plasma market, 2014-2026 (USD Million)
Chapter 8 Application Segment Analysis
8.1 Cold Plasma Market: Application Movement Analysis
8.2 Wound Healing
8.2.1 Wound healing market, 2014-2026 (USD Million)
8.3 Blood Coagulation
8.3.1 Blood coagulation market, 2014-2026 (USD Million)
8.4 Dentistry
8.4.1 Dentistry market, 2014-2026 (USD Million)
8.5 Cancer Treatment
8.5.1 Cancer treatment market, 2014-2026 (USD Million)
8.6 Other Medical Applications
8.6.1 Other medical applications market, 2014-2026 (USD Million)
Chapter 9 Regional Outlook
9.1 Cold Plasma Market Share by Region, 2016 & 2026
9.2 North America
9.2.1 North America cold plasma market, 2014 - 2026 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. cold plasma market, 2014 - 2026 (USD Million)
9.2.3 Canada
9.2.3.1 Canada cold plasma market, 2014 - 2026 (USD Million)
9.3 Europe
9.3.1 Europe cold plasma market, 2014 - 2026 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. cold plasma market, 2014 - 2026 (USD Million)
9.3.3 Germany
9.3.3.1 Germany cold plasma market, 2014 - 2026 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific cold plasma market, 2014 - 2026 (USD Million)
9.4.2 Japan
9.4.2.1 Japan cold plasma market, 2014 - 2026 (USD Million)
9.4.3 China
9.4.3.1 China cold plasma market, 2014 - 2026 (USD Million)
9.5 Latin America
9.5.1 Latin America cold plasma market, 2014 - 2026 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil cold plasma market, 2014 - 2026 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico cold plasma market, 2014 - 2026 (USD Million)
9.6 MEA
9.6.1 MEA cold plasma market, 2014 - 2026 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa cold plasma market, 2014 - 2026 (USD Million)
Chapter 10 Company Profiles
10.1 US Medical Innovations, LLC
10.1.1 Company overview
10.1.2 Product benchmarking
10.1.3 Strategic initiatives
10.2 Bovie Medical Corporation
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 neoplas tools GmbH
10.3.1 Company overview
10.3.2 Product benchmarking
10.4 Europlasma NV
10.4.1 Company overview
10.4.2 Product benchmarking
10.4.3 Strategic initiatives
10.5 P2i Limited
10.5.1 Company overview
10.5.2 Product benchmarking

Companies Mentioned

  • US Medical Innovations, LLC

  • Bovie Medical Corporation

  • neoplas tools GmbH

  • Europlasma NV

  • P2i Limited

Methodology

Loading
LOADING...